× click new topic to start your post

New - Low Grade Upper Tract (Ureter/ Renal Pelvis) Treatment "Jelmyto"

3 months 3 weeks ago #59311 by Jack R
FDA Approves Jelmyto For UTUC

April 15, 2020 -- Today, the U.S. Food and Drug Administration approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system.

While the majority of urothelial cancers occur in the bladder, UTUC corresponds to a subset of urothelial cancers that arise in the lining of the kidney or the ureter (the long, thin tube that connects that kidney to the bladder). UTUC can block the ureter or kidney, causing swelling, infections and impairment of kidney function in some patients.

This is the first approval specifically for patients with low-grade UTUC and provides an option for some patients who may otherwise require a nephroureterectomy. Jelmyto received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.

FULL ARTICLE at:

https://www.drugs.com/newdrugs/fda-approves-jelmyto-mitomycin-gel-low-grade-upper-tract-urothelial-cancer-5204.html

What's with this Bleeding ? 6/2015
DX: HG Papillary & CIS
3 Years and 30 BCG/BCG+Inf
Tis CIS comes back.
BC clear as of 5/17 !
RCC found in my one & only kidney 10/17
Begin Chemo; Cisplatin and Gemzar
8/18 begin Chemo# 3
Begin year 4 with cis
2/19 Chemo #4
9/19 NED again :)
1/2020 CIS is back...

Please Log in or Create an account to join the conversation.

  • Not Allowed: to create new topic.
  • Not Allowed: to reply.
  • Not Allowed: to add Files.
  • Not Allowed: to edit your message.
Moderators: Cynthiaeddieksara.anne

Users

Total Online: 0 Users and 234 Guests 

Statistics

Today Total Opened: 0 Today Total Answered: 0 Latest User: Beloved66
Yesterday Total Opened: 0 Yesterday Total Answered: 7
Total Posts: 53921 Total Subjects: 7069 Total Users: 6598